Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine
Clinical trial NCT04445194 · UNKNOWN
Trial details
- NCT number
- NCT04445194
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-22
- Primary completion
- 2020-10-22
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.